Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation. | Cells | 2022 | 36497086 | PubTator, text mining | PubMed |
| Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80. | Nat Cancer | 2022 | 36482233 | PubTator, text mining | PubMed |
| Triggering of lymphocytes by CD28, 4-1BB, and PD-1 checkpoints to enhance the immune response capacities. | PLoS One | 2022 | 36480493 | PubTator, text mining | PubMed |
| KLF4-PFKFB3-driven glycolysis is essential for phenotypic switching of vascular smooth muscle cells. | Commun Biol | 2022 | 36470917 | PubTator, text mining | PubMed |
| Single-cell sequencing shows cellular heterogeneity of cutaneous lesions in lupus erythematosus. | Nat Commun | 2022 | 36470882 | PubTator, text mining | PubMed |
| Rapid identification of CMV-specific TCRs via reverse TCR cloning system based on bulk TCR repertoire data. | Front Immunol | 2022 | 36466875 | PubTator, text mining | PubMed |
| Novel T-cell signature based on cell pair algorithm predicts survival and immunotherapy response for patients with bladder urothelial carcinoma. | Front Immunol | 2022 | 36466869 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the landscape of the tumor microenvironment in a skeletal undifferentiated pleomorphic sarcoma patient. | Front Immunol | 2022 | 36466840 | PubTator, text mining | PubMed |
| Immunomodulatory role of metalloproteinase ADAM17 in tumor development. | Front Immunol | 2022 | 36466812 | PubTator, text mining | PubMed |
| A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3. | Sci Rep | 2022 | 36446890 | PubTator, text mining | PubMed |
| System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer. | Aging (Albany NY) | 2022 | 36445321 | PubTator, text mining | PubMed |
| The prospect of genetically engineering natural killer cells for cancer immunotherapy. | Biol Open | 2022 | 36445164 | PubTator, text mining | PubMed |
| Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies. | Front Immunol | 2022 | 36439104 | PubTator, text mining | PubMed |
| The role of costimulatory molecules in glioma biology and immune microenvironment. | Front Genet | 2022 | 36437961 | PubTator, text mining | PubMed |
| β-Glucosylceramides and Tocopherols Regulate Development and Function of Dendritic Cells. | J Immunol | 2022 | 36426950 | PubTator, text mining | PubMed |
| A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer. | J Oncol | 2022 | 36425941 | PubTator, text mining | PubMed |
| Harnessing natural killer cells to develop next-generation cellular immunotherapy. | Chronic Dis Transl Med | 2022 | 36420177 | PubTator, text mining | PubMed |
| Strategies to enhance CAR-T persistence. | Biomark Res | 2022 | 36419115 | PubTator, text mining | PubMed |
| Identifying hub genes of calcific aortic valve disease and revealing the immune infiltration landscape based on multiple WGCNA and single-cell sequence analysis. | Front Immunol | 2022 | 36405745 | PubTator, text mining | PubMed |
| A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. | Front Immunol | 2022 | 36405735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=35